We analyzed the data from TCGA and found that LYPD2 expression was not significantly different between tumor and normal tissues in patients with GC, and that LYPD2 expression was not correlated with clinical stage or prognosis (Figure S1A–C, Supporting Information). The gene discussed is LYPD2; the disease is gastric cancer.